Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-023557

CHIEF CORP. & COMM. OFFICER gave up 3,300 shares (to pay taxes)

  • CHIEF CORP. & COMM. OFFICER acquired 6,823 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Moat Ross · CHIEF CORP. & COMM. OFFICER

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-01 Exercise or conversion : show line 1 in the form +1,741 11,156 D
2025-09-01 Exercise or conversion : show line 2 in the form +1,611 12,767 D
2025-09-01 Exercise or conversion : show line 3 in the form +2,477 15,244 D
2025-09-01 Shares withheld for taxes : show line 4 in the form −2,819 $33.49 $94,408 12,425 D
2025-09-02 Exercise or conversion : show line 5 in the form +994 13,419 D
2025-09-02 Shares withheld for taxes : show line 6 in the form −481 $34.28 $16,489 12,938 D

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2025-09-01 Grant or award : show line 7 in the form Restricted Share Unit +9,828 9,828 D
2025-09-01 Grant or award : show line 8 in the form Share Option +39,364 39,364 D
2025-09-01 Exercise or conversion : show line 9 in the form Restricted Share Unit −1,741 5,221 D
2025-09-01 Exercise or conversion : show line 10 in the form Restricted Share Unit −1,611 3,222 D
2025-09-01 Exercise or conversion : show line 11 in the form Restricted Share Unit −2,477 2,477 D
2025-09-02 Exercise or conversion : show line 12 in the form Restricted Share Unit −994 0 D
Loading xslF345X05/form4-09032025_080909.xml…